Vital Signs: Clinical Trials

37 trials of Vital Signs, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

24 completed, 6 unknown, 4 recruiting, 2 terminated. 11 Not applicable, 6 Phase 1, 6 Phase 2, 3 Phase 3, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable11Completed 8, Recruiting 2, Not yet recruiting 1
Phase 16Completed 5, Recruiting 1
Phase 26Completed 5, Recruiting 1
Phase 33Completed 1, Terminated 1, Unknown 1
Phase 42Terminated 1, Unknown 1

Follow Vital Signs: new trials by email Literature Review of Vital Signs trials Research Report on Vital Signs

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Women's Heart: Impact of Ultra-endurance and Hormonal Profile on Cardiac and Systemic Inflammatory Parameters in Female Runners
Echocardiography, Arterial ultrasound, Blood sampling - Healthy Volunteer
Not applicableNot yet recruitingFrench Cardiology Society1202027-03-202026-10-09
Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers
Psilocybin and D-Serine, Physical Examination, Vital signs - Healthy Volunteers
Phase 1RecruitingHadassah Medical Organization102025-12-112026-02-05
Endoscopic Full Thickness Suturing of Mucosal, Submucosal and Perforation Defects Using Su2ura® GI System
Su2ura® GI system, Physical Examination, Vital Signs - Endoscopic Mucosal Resection, Endoscopic Submucosal Dissection (ESD)
Not applicableRecruitingAnchora Medical252025-08-182026-01-07
EWSs and 28-Day Mortality in Geriatric ED Patients
Demographic Characteristics, Comorbidities, Vital Signs - Mortality, Clinical Deterioration
CompletedHaseki Training and Research Hospital27442025-07-012026-05-11
Efficacy of Sublingual 5-MeO-DMT for Reducing Anxiety and Depression in MCI
Sublingual administration, Electroencephalography, Biochemical mesurements - Mild Cognitive Impairment, Anxiety State
Phase 1 / Phase 2CompletedBiomind Labs Inc.202024-12-152025-04-09
Safety, Tolerability, and Efficacy of Sublingual Microdoses of 5-MeO-DMT for Depression and Anxiety
BMND08, Brain electrical activity monitor, Pharmacokinetic Study of Sublingually Administered Psychoactive Substance - Healthy Volunteers
Phase 1 / Phase 2CompletedBiomind Labs Inc.402024-10-212025-03-05
Stress Ball Use in Patients Undergoing Coronary Angiography
The Effect of Stress Ball Use on Immobilization Comfort, Pain Level and Vital Signs in Patients Undergoing Coronary Angiography - Pain
Not applicableCompletedMustafa Kemal University722024-04-242024-07-08
Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve Participants
ICF, Eligibility Assessment, Demographic data - HIV, HIV Infection
Phase 2RecruitingCode Pharma402023-07-202024-11-06
Study of Early Cancer Biomarkers in Breath Condensate in Population of Individuals With High-Risk of Lung Cancer Undergoing LDCT Screening.
Exhaled breath condensate sampling, Blood sampling, LDCT - Lung Cancer
Not applicableRecruitingThe Institute of Molecular and Translational Medicine, Czech Republic32002023-06-012026-02-12
Predicting if the Blood Pressure Will Drop After Spinal Anesthesia Using Ultrasound of the Neck
Carotid ultrasound measurement, Vital sign measurement, Spinal anesthesia - Spinal Anesthesia-induced Hypotension
CompletedCatharina Ziekenhuis Eindhoven442023-04-122024-12-02
Proof of Concept Open Label, Clinical Trial to Evaluate the Safety and Efficacy of the "FITT" Device in Diabetic Foot Ulcers Patients
Study treatment administration (TriO FITT), Physical Examination, Vital Signs - Diabetic Foot Ulcer
Not applicableCompletedTri.O Medical LTD192023-03-292026-10-08
Assessment of KM-001 - Safety, Tolerability, and Efficacy in Patients With PPPK1 or PC
KM-001 cream 1% 12 weeks treatment., Physical Examination, Vital Signs - Punctate Palmoplantar Keratoderma Type 1, Pachyonychia Congenita
Phase 1CompletedOrvida Pharma (formerly Kamari Pharma)182023-03-062025-01-15
Validation of Prognostic Accuracy of ABC ( Age, Blood Urea Nitrogen , Co-morbidities ) and Horibe Pre-endoscopy Scoring Systems in Patients With Upper Gastrointestinal Bleeding in Sohag University Hospital .
history taking , vital signs and labaratory investigations - Upper GI Bleeding
UnknownSohag University1002023-02-152023-05-25
Feasibility of Using NeoSpot at Community Settings
NeoSpot - Pregnancy Related
CompletedCentre for Infectious Disease Research in Zambia1492023-01-152026-09-25
Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19
Biochemistry blood test, Hematology blood test, D-Dimer test (coagulation) - Covid19, Corona Virus Infection
Phase 2CompletedMGC Pharmaceuticals d.o.o2402022-10-112023-03-15
Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases
Serum chemistry, Hematology, Urinalysis - Punctate Palmoplantar Keratoderma Type 1, Pachyonychia Congenita
Phase 1CompletedOrvida Pharma (formerly Kamari Pharma)142022-07-172025-01-07
Pompe & Pain - Study to Assess Nociceptive Pain in Adult Patients With Pompe Disease
Beck depression inventory fast screen (Questionnaire), Brief Pain Inventory (BPI) (Questionnaire), German Pain Inventory (Questionnaire) - Pompe Disease (Late-onset), Inclusion Body Myositis
UnknownLMU Klinikum952022-03-312023-10-10
Influence of Menstrual Cycle Stages on Female Athletes
Determination of hormone level concentrations, Jump height determination, Grip strength determination - Menstrual Cycle, Sports
CompletedUniversitat Jaume I412022-03-162022-12-21
Laparoscopic Ventral Hernia Repair with Routine Defect Closure Using Su2ura® Approximation Device
Hernia repair surgery using the Su2ura® approximation device, Physical Examination, Vital Signs - Ventral Hernia
Not applicableCompletedAnchora Medical182022-01-192025-01-21
Detection of Exhaled Methane Levels in Hemorrhagic Shock
Measurement of methane concentrations in exhaled breath, Videomicroscopy of the sublingual microcirculation, Blood gas and laboratory analysis - Hemorrhagic Shock, Trauma
UnknownSzeged University402021-11-012021-09-28

Showing 20 of 37. Sign in to see all of them.

Conditions studied

COVID-19 (3)  ·  Anxiety Disorders (2)  ·  Coronavirus Infections (2)  ·  Depression (2)  ·  Glycogen Storage Disease Type II (2)  ·  Keratosis palmoplantaris papulosa (2)  ·  Myositis, Inclusion Body (2)  ·  Pachyonychia Congenita (2)  ·  Pulmonary Disease, Chronic Obstructive (2)  ·  Spinal Muscular Atrophies of Childhood (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Adenomatous Polyps (1)  ·  Cardiovascular Diseases (1)  ·  Clinical Deterioration (1)  ·  Cognitive Dysfunction (1)

Sponsors

Anchora Medical (2)  ·  Biomind Labs Inc. (2)  ·  LMU Klinikum (2)  ·  MGC Pharmaceuticals d.o.o (2)  ·  Orvida Pharma (formerly Kamari Pharma) (2)  ·  Baylor Research Institute (1)  ·  Catharina Ziekenhuis Eindhoven (1)  ·  Centre for Infectious Disease Research in Zambia (1)  ·  Chosun University Hospital (1)  ·  Code Pharma (1)  ·  David Hasan (1)  ·  French Cardiology Society (1)  ·  Hadassah Medical Organization (1)  ·  Haseki Training and Research Hospital (1)  ·  Hospital Clinic of Barcelona (1)

Countries

Israel (7)  ·  United States (5)  ·  Spain (3)  ·  United Kingdom (3)  ·  Argentina (2)  ·  Denmark (2)  ·  Germany (2)  ·  Turkey (Türkiye) (2)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  Czechia (1)  ·  Egypt (1)  ·  France (1)  ·  Hungary (1)

Top investigators

Martin A. Bruno, PhD (2)  ·  Stephan Wenninger, PD Dr. med. (2)  ·  Adem Az (1)  ·  Albert Manasyan, MD (1)  ·  Arthur Bouwman, Professor (1)  ·  Carlos Hernando-Domingo, Doctor (1)  ·  Craig S Conoscenti, MD (1)  ·  Eladio Collado-Boira, Doctor (1)  ·  Erika F. Christensen, MD, Medical director (1)  ·  Isabel Blanco, MD, PhD (1)

Results publications

PMID 19411668, PMID 26391583, PMID 28430315, PMID 32252135, PMID 32434791, PMID 33845761, PMID 34470496, PMID 35298560, PMID 35793921, PMID 37331563, PMID 40057795, PMID 40198758, PMID 40232947, PMID 40659913, PMID 41047463

NIH funding

R01HL142042 (1)